Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Clinical Results from AFFIRM: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial To Determine the Efficacy and Safety of Natalizumab in Patients with Relapsing Multiple Sclerosis (MS)
MS and Related Diseases
(-)
003
Authors/Disclosures
Thomas W. Leung, MD (The Chinese University of Hong Kong) Dr. Leung has nothing to disclose.
Jillian Alderson, MD (Overlook Medical Center) No disclosure on file
Elena Lopez Garcia No disclosure on file
No disclosure on file
Neishay Ayub, MD (Brown Neurology) The institution of Dr. Ayub has received research support from Brown Physicians Incorporated. The institution of Dr. Ayub has received research support from Pappitto Opportunity Connection.
Bonaventure Ip The institution of Bonaventure Ip has received research support from Hong Kong College of Physicians.
Ka S. Wong, MD (Prince of Wales Hospital) No disclosure on file
Kathie Lin, MD (Stanford Neuromuscular Department) Dr. Lin has nothing to disclose.
No disclosure on file
Sandeep Kumar, MD Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for CRICO.
Christine Schuhmann (Klinikum der Johann Wolfgang Goethe-Universit) No disclosure on file